modelFluvoxamine_Strauss1999_reference

Extends from Pharmacolibrary.Pharmacokinetic.Models.PK_1C_enteral.

Information

name:fluvoxamine
ATC code:N06AB08
model:one compartment, oral dosing (PK_1C_enteral)
source:Strauss WL et al. 1999
population:adults (human brain 19F MRS data)
measured compound:fluvoxamine
review:curated candidate
record page:pharmacolibrary-docs

Parameters as reported in the paper

parametervalueunitmeaning
brain volume of distribution1.12L/kgV
clearance1.01L/hourCL
bioavailability of fluvoxamine to the brain from plasma1.85Fab
Ka (h-1)1.46h-1kabs

About fluvoxamine

Fluvoxamine is a selective serotonin reuptake inhibitor antidepressant used for depression, obsessive-compulsive disorder, anxiety disorders and panic disorder. It is an approved medicine used worldwide in everyday clinical practice, mainly for obsessive-compulsive disorder and depression.

Summary written by glm-5.3-flash from Wikidata Q409236 and the WHO ATC classification; not checked by a person.

Identity, molar mass and metabolites: Fluvoxamine.

References

  1. Strauss WL et al. (1999). Characterization of human brain pharmacokinetics using a two-compartment model. Biological psychiatry 45(10):1384–1388. DOI:10.1016/s0006-3223(98)00324-2 PUBMED:10349045

Parameters

TypeNameDefaultDescription
RealCl_ref2.8055555555555556e-07Cl [m3/s]
RealVd_ref0.07840000000000001Vd [m3]
Modelica.Units.SI.Massweight (from PK_1C)75patient weight (kg)
Modelica.Units.SI.SpecificVolumeVdPerKg (from PK_1C)0.0009Volume of distribution per kg (default 0.9 L/kg)
Modelica.Units.SI.MassFractionF (from PK_1C)1bioavailability (0-1)
Pharmacolibrary.Types.ClearanceCl (from PK_1C)2.7777777777777776e-7clearance
Modelica.Units.SI.TimeadminTime (from PK_1C)60first administration time (s)
Modelica.Units.SI.TimeadminDuration (from PK_1C)600administration duration (s)
Modelica.Units.SI.TimeadminPeriod (from PK_1C)8*60*60period of administration (default 8 hours)(s)
Pharmacolibrary.Types.MassadminMass (from PK_1C)1e-4administration mass (mg)
IntegeradminCount (from PK_1C)8number of dose administered (1)
Pharmacolibrary.Types.VolumeVd (from PK_1C)VdPerKg*weightVolume of distribution (m3)
Pharmacolibrary.Types.TransferRateka (from PK_1C_enteral)0.016666666666666666first order absorption rate
Modelica.Units.SI.TimeTlag (from PK_1C_enteral)600delay between oral administration and absorption (default 10min)
Info › Therapeutic range (metadata, not used in equations)
Pharmacolibrary.Types.MassConcentrationCmin (from PK_1C)0.004minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCmax (from PK_1C)0.008maximal therapeutic range
Pharmacolibrary.Types.MassConcentrationCtox_peak (from PK_1C)0.012toxicity peak level
Pharmacolibrary.Types.MassConcentrationCtox_trough (from PK_1C)0.006toxicity trough level
Info › Substance metadata
Modelica.Units.SI.MolarMassMM (from PK_1C)0molar mass [kg/mol]; 0 = not supplied (molar concentrations are then 0)
Info › Substance metadata (not used in equations)
Pharmacolibrary.Types.DoseLD50 (from PK_1C)0median lethal dose [mg/kg]; 0 = unknown

Connectors

TypeNameDefaultDescription
Types.ConcentrationOutputC_central (from PK_1C)
Interfaces.ConcentrationPort_bcentralCPort (from PK_1C)

Components

TypeNameDefaultDescription
Pharmacokinetic.NoPerfusedTissueCompartmentcentral (from PK_1C)
Pharmacokinetic.ClearanceDrivenEliminationelim (from PK_1C)
Sources.PeriodicDoseperiodicDose (from PK_1C)
Modelica.Units.SI.Timet1_2 (from PK_1C)central-compartment elimination half-life = ln(2)*Vd/Cl (1-compartment approximation; NOT the terminal half-life of 2-/3-compartment models)

Revisions

  • 11/2026 generated by pharmacolibrary-dev export.pharmacolibrary_models from Strauss_1999: parameters extracted from the paper by the pharmacolibrary-dev pipeline, model built by its engineer, reviewed: curated candidate